Bovine anterior-pituitary microsomal fractions exhibit high-affinity, saturable and reversible binding of inositol 1,4,5-[32P]trisphosphate; 50%O of the labelled ligand is displaced by 3.5 nM-inositol 1,4,5-trisphosphate, 0.5/tM-inositol 1,4-bisphosphate and 10 gM-ATP. Inositol 1,4,5-trisphosphate induces the release of Ca2+ from the microsomal vesicles (half-maximal effect at 290 nM), and its action is potentiated by inositol tetrakisphosphate (half-maximal effect at 4,UM).
INTRODUCTION
Inositol 1,4,5-trisphosphate (InsP3), formed through the phosphodiesteratic hydrolysis of phosphatidylinositol 4,5-bisphosphate (Berridge, 1983; induces the release of Ca2+ from the endoplasmic reticulum (as reviewed by Abdel-Latif, 1986; Berridge, 1986; Irvine, 1986;  Williamson, 1986) and thus triggers the biological response to 'calciummobilizing' hormones and neurotransmitters. In order to explore the mode of the Ca2+-releasing action of InsP3, we characterized its binding to specific intracellular binding sites. The high affinity, saturable and reversible binding of InsP, to non-mitochondrial intracellular sites in permeabilized guinea-pig hepatocytes and rabbit peritoneal polymorphonuclear cells showed a strong correlation with Ca2+ release in terms of concentration-dependence as well as specificity (Spat et al., 1986a) . We localized the binding site in the microsomal fraction of rat liver (Spat et al., 1986b) and bovine adrenal cortex (Baukal et al., 1985) . In order to generalize and extend these observations, in the present experiments we studied the binding characteristics and effect of InsP3 in a hitherto non-examined type of tissue, the peptide-hormone-secreting anterior pituitary. InsP3 is formed in the cells of the anterior pituitary in response to gonadotropin-releasing hormone (Kiesel et al., 1986) , thyrotropin-releasing hormone (Martin, 1983; Rebecchi & Gershengorn, 1983; Drummond & Raeburn, 1984) or angiotensin II (Canonico & Macleod, 1986; Enjalbert et al., 1986) . InsP3 induces Ca2+ release in permeabilized pituitary-tumour cells (Gershengorn et al., 1984; Biden et al., 1986 (Spiit et al., 1986a) , was obtained from du Pont-New England Nuclear. Its specific radioactivity at the time of the experiments, as estimated by self-displacement analysis (Catt et al., 1976) , was 7-10 Ci/mmol. InsP3 and InsP4 were given by Dr. R. F. Irvine (Cambridge, U.K.). InsP2 was obtained from Amersham International. All other chemicals were purchased from Sigma or Serva.
Fresh bovine pituitaries were collected in liquid N2 and stored at -80°C until homogenization. The separated anterior pituitary was homogenized first in a Polytron homogenizer and then with a glass-Teflon Potter homogenizer at 4 'C. Microsomal fraction (microsomes) was prepared as described by Dawson & Irvine (1984) , with the modification that the pellet obtained after the first 35000 g centrifugation was resuspended in 250 mmsucrose/5 mM-Hepes/ 10 mM-KCl/ 1 mM-dithiothreitol/ 0.15 mM-EGTA (pH 7.0) and re-centrifuged at 35000 g for 30 min.
For binding studies, microsomal vesicles (250 ,ug of protein) were incubated in a cytoplasmic-type medium (pH 7.0), containing 10 mM-NaCl, 100 mM-KCl, 0.513 mM-MgCl2, 1 mM-NaH2PO4, 10 mM-Hepes, 1 mM-EGTA, 0.330 mM-CaCl2 and I mg of bovine serum albumin/ml. The calculated (Fabiato & Fabiato, 1979) free Ca2+ and Mg2+ concentrations were about 235 nm and 0.5 mm respectively. The medium was completed with 8-13 nCi of [32P]InsP3/ml. Except for kinetic studies, the volume of the incubation medium was 500,l. Non-specific binding was determined in the presence of 2-10,uM-InsP3. Incubations were carried out in a shaking ice bath, for 5 min (except for kinetic studies) and terminated by filtration through GF/C filters as described by Spat et al. (1986b) . All samples were counted for radioactivity at least twice for 20 min by liquid-scintillation spectrometry. Binding parameters were estimated by graphical analysis of the limiting slopes of the Scatchard cuirve (Thakur et al., 1980) . For Ca2+-transport measurements, microsomes (about 1 mg/ml) were incubated at 30°C in the fol-lowing medium: 100 mM-KCl, 10 mM-NaCl, 1 mMMgCl2, 10 mM-Hepes, 1.5 mM-ATP, 4 mM-phosphocreatine, 20 ,tg ofcreatine kinase/ml, 0.5 mM-dithiothreitol and 1 ,ug of oligomycin/ml, pH 7.0. The free Ca2+ concentration was monitored with a Ca2+-selective electrode (Lukaics & Fonyo, 1986) , calibrated with calcium buffers (Tsien & Rink, 1980) . Ca2+ release was quantified on the basis of the electrode response to known amounts of CaCl2 added after microsomes reached the steady-state Ca2+ concentration.
RESULTS AND DISCUSSION
Pituitary microsomal binding sites for InsP3 obey all the criteria for receptor function: high affinity, saturability, reversibility, specificity, and also the ability to trigger the biological response. Binding of [32P]InsP3 (equivalent to 1.3 nM) by pituitary microsomes was complete within 10 s (n = 3; results not shown). Addition of excess InsP3 induced the dissociation of the ligand-receptor complex, and in two experiments half-times of 3 and 5 min were observed (Fig. 1) . The binding was saturable, and half-maximal displacement of the tracer was attained by 3.5 nm unlabelled ligand on average (Fig. 2) . This value is comparable with that observed in rat liver (8 nM) (Spat et al., 1986b) and bovine adrenocortical microsomes (5 nM) (Baukal et al., 1985) as well as in a bovine pituitary particulate fraction (0.9 nM) (Guillemette et al., 1987) obtained by a homogenization and isolation method different from that used in the present work. Accordingly, it may be assumed that similar or identical binding sites are to be found in different mammalian tissues. Scatchard analysis of the Half-maximal release was attained with 0.29+0.10 /MInsP3 (mean+ S.E.M., n = 4), a concentration comparable with that described in other cell types (cf. and with estimated intracellular concentrations of InsP3 (Bradford & Rubin, 1986; ). This concentration is, however, two orders of magnitude higher than that required for half-maximal occupancy of the InsP3 receptor. This discrepancy may be due to the affinity of ATP (present at 1.5 mm in the Ca2+-release studies) for InsP3 receptors. As shown in Fig. 2 , ATP displaced [32P]InsP3 with an IC50 of 10/,M.
Binding and effect of InsP3 were compared with that of InsP2. This metabolic product of InsP3 does not evoke Ca2+ release in permeabilized pancreatic acinar cells (Streb et al., 1983) , hepatocytes (Burgess et al., 1984) or Swiss-mouse 3T3 cells . In the present experiments a 50% displacement of [32P]InsP3 was achieved by 0.5 /LM-InsP2 (of unknown purity) (n = 2). It did not induce Ca2+ release when applied in concentrations up to 12 /tM (results not shown). [In evaluation of the Ca2+ curves, correction has been made for the Ca2+-like contamination of Ins(1,4)P2.]
The present study was the first to examine the effect of the recently described inositol metabolite InsP4 (Batty et al., 1985; Heslop et al., 1985) on the binding of InsP3. In accordance with previous observations (Hansen et al., 1986; Wollheim & Biden, 1987) , InsP4, in concentrations up to 8 /M, failed to induce Ca2+ release. We observed, however, that it potentiated the Ca2+-releasing effect of InsP3. In two separate experiments, where InsP3 was applied at 0.22 and 0.55 #M respectively, half-maximal potentiation was attained by 4#sM-InsP4 (Fig. 3a) . The extent of maximal Ca2+ release increased by 27%, and the EC50 of InsP3 decreased by 30% on average (Fig. 3b) Hansen et al., 1986) , where the plasma membrane is freely diffusible to Ca2+. Experiments are now needed to localize the site of action of InsP4, a potential new second messenger.
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